Nutrisense
- Industry
- Health Technology
- Founded Year
- 2019
- Headquarters
- Chicago, Illinois, USA
- Employee Count
- 161
Key People
- Alex Skryl - Chief Executive Officer
- Dan Zavorotny - Chief Operating Officer
- Kara Collier - Vice President of Health
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team comprises first-time entrepreneurs with over 10 years of experience in relevant fields.
The leadership team includes individuals with significant experience in healthcare and technology. For instance, CEO Alex Skryl has a background in computer engineering and chemistry, and previously co-founded Trusted Childcare. COO Dan Zavorotny has experience as a management consultant at KPMG, focusing on healthcare. This blend of technical and healthcare expertise is advantageous for NutriSense's mission.
- Clinical Need
-
Aspect: Very Strong
Summary: NutriSense addresses a critical need in metabolic health management.
With rising concerns over metabolic disorders such as diabetes and obesity, there is a significant demand for solutions that offer real-time health monitoring and personalized guidance. NutriSense's platform, which combines continuous glucose monitoring with dietitian support, directly addresses this need, providing users with actionable insights to improve their health outcomes.
- Competition
-
Aspect: Somewhat crowded
Summary: The market has several players offering similar metabolic health solutions.
The health technology sector, particularly in metabolic health monitoring, has seen the emergence of multiple companies offering continuous glucose monitoring and personalized coaching. Competitors include Levels Health and Signos, which provide similar services. This competitive landscape necessitates that NutriSense differentiates itself through superior technology, user experience, or additional services to capture and retain market share.
- Technical Challenge
-
Aspect: Predictable
Summary: The technology involved is well-established and manageable.
The core technologies utilized by NutriSense, such as continuous glucose monitors (CGMs) and data analytics platforms, are mature and widely used in the industry. Integrating these technologies into a cohesive platform presents a predictable level of technical challenge, allowing the company to focus on user experience and service quality rather than overcoming significant technical hurdles.
- Patent
-
Aspect: None
Summary: No proprietary patents have been identified.
NutriSense's platform relies on existing technologies and does not appear to have proprietary patents protecting its innovations. While this approach allows for rapid development and deployment, it may also expose the company to competitive pressures, as other firms can replicate similar offerings without legal barriers. Establishing unique features or services could help mitigate this risk.
- Financing
-
Aspect: Well-funded
Summary: NutriSense has secured substantial funding to support its growth.
In July 2022, NutriSense raised $25 million in a Series A funding round led by 1315 Capital. This significant investment provides the company with the resources needed to expand its operational team, enhance its technology infrastructure, and increase market outreach. Such financial backing is crucial for scaling operations and achieving long-term success in the competitive health tech industry.
- Regulatory
-
Aspect: 510k/PMA
Summary: NutriSense's platform aligns with existing regulatory frameworks.
NutriSense utilizes continuous glucose monitors (CGMs) that are FDA-approved medical devices. By integrating these devices with their platform, the company ensures compliance with regulatory standards. Additionally, providing personalized dietitian coaching aligns with healthcare service regulations. Maintaining adherence to these standards is essential for building trust with users and healthcare professionals.
Opportunity Rollup
- Odds of Success
- 3.6
- Peak Market Share
- 4.75
- Segment CAGR
- 9.5%
- Market Segment
- Health Technology
- Market Sub Segment
- Metabolic Health Monitoring
Year Post Launch | Market Penetration (%) |
---|---|
1 | 0.24 |
2 | 0.71 |
3 | 1.66 |
4 | 3.32 |
5 | 4.75 |
Key Takeaway
NutriSense is well-positioned in the growing metabolic health market, leveraging technology and personalized coaching to meet increasing consumer demand.